Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1201440019 | Ursodiol 300mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1214429016 | Ursodiol 300mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3472386014 | Ursodeoxycholic acid 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3472387017 | Ursodiol 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3472388010 | Product containing ursodiol 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3472389019 | Product containing ursodeoxycholic acid 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490163013 | Product containing ursodeoxycholic acid 300 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568649015 | Product containing only ursodiol 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568650015 | Product containing only ursodeoxycholic acid 300 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568651016 | Product containing only ursodeoxycholic acid 300 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683898015 | Ursodeoxycholic acid 300 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3683899011 | Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3683900018 | Ursodiol 300 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3683901019 | Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 105042601000001111 | Ursodiol 300mg capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Is a | Product containing ursodeoxycholic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has active ingredient | Gallstone solubilizing agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has active ingredient | Ursodiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has active ingredient | Bile | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has active ingredient | Ursodeoxycholic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has active ingredient | Ursodeoxycholic acid | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has basis of strength substance | Ursodeoxycholic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Has precise active ingredient | Ursodeoxycholic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Is a | Product containing ursodeoxycholic acid in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral capsule | Is a | Product containing only ursodeoxycholic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR